Synthesis, biological evaluation and molecular docking studies of 6-Aryl-2-styrylquinazolin-4(3H)-ones

  • Emmanuel Ndubuisi Agbo
  • , Tshepiso Jan Makhafola
  • , Yee Siew Choong
  • , Malose Jack Mphahlele
  • , Ponnadurai Ramasami

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Abstract

Suzuki-Miyaura cross-coupling of 6-bromo-2-styrylquinazolin-4(3H)-ones with arylboronic acids afforded a series of novel 6-aryl-2-styrylquinazolin-4(3H)-ones. These compounds were evaluated for potential anticancer properties against the human renal (TK-10), melanoma (UACC-62) and breast cancer (MCF-7) cell lines. Their antimicrobial properties were also evaluated against six Gram-positive and four Gram-negative bacteria, as well as two strains of fungi. Molecular docking studies (in silico) were conducted on compounds 5a, b, d and 6a, b, d-f to recognize the hypothetical binding motif of the title compounds within the active site of the dihydrofolate reductase and thymidylate synthase enzymes.

Original languageEnglish
Article number21010028
JournalMolecules
Volume21
Issue number1
DOIs
Publication statusPublished - 1 Jan 2016
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • 6-aryl-2- styrylquinazolin-4(3h)-ones
  • 6-bromo-2-styrylquinazolin-4(3h)-ones
  • Antimicrobial activity
  • Docking studies
  • In vitro cytotoxicity
  • Suzuki-miyaura cross-coupling

ASJC Scopus subject areas

  • Analytical Chemistry
  • Chemistry (miscellaneous)
  • Molecular Medicine
  • Pharmaceutical Science
  • Drug Discovery
  • Physical and Theoretical Chemistry
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'Synthesis, biological evaluation and molecular docking studies of 6-Aryl-2-styrylquinazolin-4(3H)-ones'. Together they form a unique fingerprint.

Cite this